FDA OKs Amitiza for treatment of IBS-C April 30, 2008 | User rating: not rated yet | No comments yet
The U.S. Food and Drug Administration announced approval of Amitiza (lubiprostone) to treat constipation associated with irritable bowel syndrome. | |
FDA rejects Singulair-Claritin combination April 30, 2008 | User rating: not shown ( 2 vote(s) ) | No comments yet
The U.S. Food and Drug Administration rejected a proposed pill that would combine the drugs Claritin and Singular, Schering-Plough said. | |
FDA OKs Relistor for opioid patients April 28, 2008 | User rating: not shown ( 2 vote(s) ) | No comments yet
The U.S. Food and Drug Administration has approved Relistor (methylnaltrexone bromide) to help restore bowel function in patients receiving opioids. | |
Osteoporosis drug may be associated with irregular heartbeat April 28, 2008 | User rating: not shown ( 4 vote(s) ) | No comments yet
Alendronate, a medication used to prevent fractures in women with osteoporosis, may be associated with an increased risk of atrial fibrillation, a type of abnormal heart rhythm, according to a report in the April 28 issue ... | |
Osteoporosis drug fosamax linked to heart problem April 28, 2008 | User rating: 4.5 / 5 after 8 vote(s)
| No comments yet
Women who have used Fosamax are nearly twice as likely to develop the most common kind of chronically irregular heartbeat (atrial fibrillation) than are those who have never used it, according to research from Group Health ... | |
Baxter may stay out of Heparin business April 25, 2008 | User rating: not rated yet | No comments yet
The head of Baxter International Inc. said the company has not decided whether it will resume selling the blood thinner heparin in the United States. | |
New technology for boosting vaccine efficiency April 24, 2008 | User rating: not rated yet | No comments yet
One of the most pressing biomedical issues is the development of techniques that increase the efficiency of vaccines. In a paper published on April 24, 2008 in the journal Vaccine, a Massachusetts’s biotechnology company, ... | |
New adult ADHD drug receives FDA approval April 24, 2008 | User rating: not shown ( 1 vote(s) ) | No comments yet
The U.S. Food and Drug Administration has approved the first prodrug designed for once-daily treatment of adults with ADHD. | |
Experimental drug shows promise in treating certain lymphomas April 16, 2008 | User rating: not shown ( 1 vote(s) ) | No comments yet
New clinical data showed some cancer patients with recurrent lymphoma benefited from an experimental drug called AME-133v, said a researcher at the University of Alabama at Birmingham (UAB). | |
Older epilepsy drugs do not prevent first seizure from brain tumors April 16, 2008 | User rating: not rated yet | No comments yet
Many physicians prescribe antiepileptic medications to patients with brain tumors, even to those with no seizure history. Now, a new review of studies casts doubt on the wisdom of using these drugs — which can carry serious ... | |
Antipsychotic drugs increase risk of developing pneumonia in elderly April 15, 2008 | User rating: not shown ( 3 vote(s) ) | No comments yet
Elderly patients who use antipsychotic drugs have a 60 percent increased risk of developing pneumonia compared to non-users. This risk is highest in the first week following prescription and decreases gradually thereafter. ... | |
Antidepressants account for only 10% of fall in suicide rates among older people April 15, 2008 | User rating: not rated yet | No comments yet
The use of antidepressants is likely to account for only 10 per cent of the fall in suicide rates among middle aged and older people, suggests a large study in the Journal of Epidemiology and Community Health. Globally, more ... | |
Industrial chemical found in Cubicin April 10, 2008 | User rating: not rated yet | No comments yet
The U.S. Food and Drug Administration said Cubist Pharmaceuticals is warning that an industrial chemical has been found in the antibiotic Cubicin. | |
No 'convincing evidence' that glitazones work better than older diabetes drugs April 10, 2008 | User rating: not shown ( 3 vote(s) ) | No comments yet
There is no convincing evidence that the newer class of diabetes drugs, known as glitazones, offer real advantages over other diabetes drugs, when used on their own, concludes the Drug and Therapeutics Bulletin (DTB). | |
Diabetes drug may hold potential as treatment for epilepsy April 09, 2008 | User rating: not shown ( 3 vote(s) ) | No comments yet
Metformine, a widely used diabetic drug, might also be an effective and safe therapy for epilepsy, researchers report. This new approach may be especially helpful for the subset of patients who have recurrent seizures despite ... | |
PhysOrg Video
- Hi-Tech Exhibit Sets Sail - video , July 24
- Raytheon Thumbing Its Way Into Combat - video , July 18
- Main Street Going Green - video , July 17
- How to Remember Dreams - video , July 14
- Cosmonauts Risk Life, Remove Explosive Bolt - video , July 11
- Oil Maverick Pushes Wind Power - video , July 9
- PhysOrg Video »
Most popular stories
-
A dash of lime -- a new twist that may cut CO2 levels back to pre-industrial levels,
July 21, 2008
-
The Pole star comes to life again,
July 21, 2008
-
Game characters get smarter and less predictable,
July 13, 2008
-
Volcanic eruptions wiped out ocean life 93 million years ago,
July 16, 2008
-
Japanese team developing palm-held 3D display,
July 14, 2008
- Most popular »
News Pix
-
Scientists identify cells for spinal-cord repair,
16 hours ago
-
NIST Membrane Model May Unlock Secrets of Early-Stage Alzheimer's,
17 hours ago
-
Engineers Prove Graphene is the Strongest Material,
July 22, 2008
-
Researchers offer glimpse of rare mutant cells,
July 22, 2008
- More news pix »
PhysOrg Forum
Video
Editorials
Free Magazines
Free White Papers
PhysOrg Jobs
Newsletter
Goto Archive
Suggest a story idea
Send feedback
